Back to Search
Start Over
ND3 SHORT- AND LONG-TERM DISABILITY BURDEN AMONG EMPLOYED PATIENTS RECEIVING DISEASE-MODIFYING TREATMENT FOR MULTIPLE SCLEROSIS.
- Source :
-
Value in Health . 2019 Supplement 3, Vol. 22, pS412-S412. 1p. - Publication Year :
- 2019
-
Abstract
- This study examined the short-term disability (STD) and long-term disability (LTD) burden (as measures of severe productivity loss) among employees with multiple sclerosis (MS) initiating disease-modifying treatments (DMTs). Oral DMT initiators had the lowest percentage of short-term disability claims and days per long-term disability claim, suggesting productivity benefits in severe productivity loss with early access to orals. [Extracted from the article]
- Subjects :
- *MULTIPLE sclerosis
*DISABILITIES
*DATABASE management
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 22
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 140396551
- Full Text :
- https://doi.org/10.1016/j.jval.2019.09.079